Cargando…

Neumonía neumocócica en pacientes con infección por SARS-CoV-2: serie de 17 casos en la Región de Murcia

INTRODUCTION: Currently the prevalence of pneumococcal coinfection in patients with COVID-19 is unknown. In this work we present its clinical characteristics, evolution and treatment. MATERIAL AND METHODS: Retrospective data collection from August to October 2020 in two hospitals in the Murcia regio...

Descripción completa

Detalles Bibliográficos
Autores principales: Escudero, Encarnación Moral, Torres, Alicia Hernández, Piloto, Aychel Elena Roura, Iglesias, Helena Albendín, Ballesta, Ana Peláez
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedad Española de Quimioterapia 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8638830/
https://www.ncbi.nlm.nih.gov/pubmed/34266230
http://dx.doi.org/10.37201/req/151.2020
Descripción
Sumario:INTRODUCTION: Currently the prevalence of pneumococcal coinfection in patients with COVID-19 is unknown. In this work we present its clinical characteristics, evolution and treatment. MATERIAL AND METHODS: Retrospective data collection from August to October 2020 in two hospitals in the Murcia region. RESULTS: Eighteen patients had COVID-19 diagnosed by PCR and pneumococcal infection confirmed by antigenuria, which represented a prevalence of 2%. A total of 88% had radiological alterations upon admission (two patients had an X-ray within normality) and 29% had elevated procalcitonin. Mortality in our series was 12%. CONCLUSIONS: It could be reasonable to consider the start of antimicrobial therapy in those cases in which there is a moderate or high suspicion of bacterial coinfection, being essential the early suspension of antibiotic treatment if it is not confirmed.